CIK 0001478320 · Large accelerated filer
Adaptive Biotechnologies Corp
Sign in to watch- Ticker
- ADPT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- WA
- Entity type
- operating
- EIN
- 270907024
- Phone
- 206-659-0067
- Business address
- 1165 EASTLAKE AVE E, SEATTLE, WA, 98109
- Former names
- Adaptive TCR Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $33,491,115
- in 20 filings, $14.5M under 10b5-1 plans
Net −$33,491,115. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-06-22 | ROBINS CHAD M CEO and Chairman | Sale | −13,503 | $46.15 | $623K | 1,778,180 |
| 2020-06-22 | ROBINS CHAD M CEO and Chairman | Option exercise · Stock Option (Right to Buy) | −33,132 | 348,748 | ||
| 2020-06-22 | HILL NANCY LOUISE EVP, Operations & Program Mana | Option exercise | +19,000 | $0.84 | $16K | 29,000 |
| 2020-06-22 | HILL NANCY LOUISE EVP, Operations & Program Mana | Sale | −4,306 | $44.66 | $192K | 24,694 |
| 2020-06-22 | HILL NANCY LOUISE EVP, Operations & Program Mana | Sale | −14,694 | $45.38 | $667K | 10,000 |
| 2020-06-22 | HILL NANCY LOUISE EVP, Operations & Program Mana | Option exercise · Stock Option (Right to Buy) | −19,000 | 121,000 | ||
| 2020-06-19 | BENZENO SHARON Chief Business Development Off | Option exercise | +417 | $6.27 | $3K | 417 |
| 2020-06-19 | BENZENO SHARON Chief Business Development Off | Sale | −417 | $45.00 | $19K | 0 |
| 2020-06-19 | BENZENO SHARON Chief Business Development Off | Option exercise · Stock Option (Right to Buy) | −417 | 4,167 | ||
| 2020-06-19 | ROBINS CHAD M CEO and Chairman | Option exercise | +24,560 | $0.33 | $8K | 1,802,740 |
| 2020-06-19 | ROBINS CHAD M CEO and Chairman | Sale | −24,160 | $44.91 | $1.1M | 1,778,580 |
| 2020-06-19 | ROBINS CHAD M CEO and Chairman | Sale | −400 | $45.52 | $18K | 1,778,180 |
| 2020-06-19 | ROBINS CHAD M CEO and Chairman | Option exercise · Stock Option (Right to Buy) | −24,560 | 381,880 | ||
| 2020-06-18 | ROBINS CHAD M CEO and Chairman | Option exercise | +16,680 | $0.33 | $6K | 1,794,860 |
| 2020-06-18 | ROBINS CHAD M CEO and Chairman | Sale | −16,680 | $44.41 | $741K | 1,778,180 |
| 2020-06-18 | ROBINS CHAD M CEO and Chairman | Option exercise · Stock Option (Right to Buy) | −16,680 | 406,440 | ||
| 2020-06-18 | LO FRANCIS Chief People Officer | Option exercise | +2,000 | $7.80 | $16K | 2,000 |
| 2020-06-18 | LO FRANCIS Chief People Officer | Sale | −2,000 | $44.34 | $89K | 0 |
| 2020-06-18 | LO FRANCIS Chief People Officer | Option exercise · Stock Option (Right To Buy) | −2,000 | 198,000 | ||
| 2020-06-17 | ROBINS CHAD M CEO and Chairman | Option exercise | +28,440 | $0.33 | $9K | 1,806,620 |
Page 101 of 120 · 2,386 trades